Infection and Drug Resistance
Volume 15, 2022 - Issue
Open access
225
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH
Ceftolozane/Tazobactam Activity Against Drug-Resistant Pseudomonas aeruginosa and Enterobacterales Causing Healthcare-Associated Infections in Eight Asian Countries: Report from an Antimicrobial Surveillance Program (2016–2018)
Michael Pfaller1 JMI Laboratories, North Liberty, IA, USA;2 University of Iowa College of Medicine, Iowa City, IA, USAView further author information
, Dee Shortridge1 JMI Laboratories, North Liberty, IA, USACorrespondence[email protected]
View further author information
, View further author information
Wei-Ting Chen3 Merck & Co., Inc, Kenilworth, NJ, USAView further author information
, Helio Sader1 JMI Laboratories, North Liberty, IA, USAView further author information
& Mariana Castanheira1 JMI Laboratories, North Liberty, IA, USAView further author information
Pages 6739-6753
|
Received 30 Aug 2022, Accepted 14 Nov 2022, Published online: 22 Nov 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.